pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

FDA nominee Heidi Overton’s confirmation won’t be voted on before the midterm elections

Sep 29, 2026·read at STAT ↗Neutral

The Senate health committee is set to vote on three HHS leadership nominees on Wednesday, but the nomination for FDA commissioner Heidi Overton is not among them.

Overton’s confirmation has been pushed past the upcoming midterm elections, meaning the Senate will not hold a vote on her appointment before the November polls.

The week also includes a deadline for states to decide participation in the GENEROUS pilot that would allow Medicaid to purchase drugs at foreign prices, a visit by CMS Administrator Mehmet Oz to promote the CHOICE tax‑free employer benefit, and the annual U.S. Alcohol Policy Alliance conference in Arlington.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Overton won’t get a vote before midterms”

read at STAT ↗
552 words · retrieved 53m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ABBVIEASTRAZENECALILLYSummit Therapeutics Inc.
drugs
insulin
topics
Approval

related stories

  • 4h agoSTAT+: AstraZeneca invests $2 billion in Summit TherapeuticsSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 7h agoSTAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four yearsSTAT
  • 9h agoSTAT+: Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midtermsSTAT
  • 1d agoSTAT+: It really is bleak out there, and list prices matterSTAT